How MFN Raises the Possibility of a ‘Worst of Both Worlds’ Approach to International Drug Pricing
Shares:
Programming Note: Cost Curve is probably off tomorrow, almost certainly off Friday, and definity off Monday. I’ll catch everyone up next week. J.P. Morgan put, arguably, the two hottest companies
Inflection Point If you’re into the IRA, it’s worth carving out a few minutes today to read this white paper from Avalere on the development path of cardiovascular medicines and
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.